

Chief State Medical Examiner
PO Box 360 August 3, 2023 |
Judith M. Persichilli |
TRENTON – The New Jersey Commission on Cancer Research (NJCCR) has awarded nearly $3.5 million in state Fiscal Year 2023 funding to 21 peer-reviewed cancer research grants and fellowships to support discovery-oriented cancer research.
The 11-member NJCCR is the state’s only cancer commission that promotes basic, translational, fellowships and pilot cancer research grants to qualified research institutions in New Jersey.
Investing in cancer research is the foundation of innovation and cancer discoveries from the laboratory to the bedside and helps secure the future pool of scientists in New Jersey. Decades of research have enabled the NJCCR to award more than $52 million for 915 peer-reviewed cancer research grants and fellowships.
NJCCR remains committed to awarding qualified research institutions cancer research grants to support the next generation of scientists in New Jersey.
The following principal investigators received awards in this funding cycle:
Pilot Research Grants
Predoctoral Fellowship
Postdoc Fellowship
Pediatric Research Grants
The New Jersey Commission on Cancer Research was created in 1983 by P.L. 83, c. 6, which is also known as the Cancer Research Act. The mission and vision of the NJCCR is to promote significant and original research into the causes, prevention, and treatment of cancer and serve as a resource to providers and consumers of cancer services. This year marks the commission’s 40th anniversary. For more information on the commission, visit www.nj.gov/health/ces/njccr.